A large scale clinical trial performed at the institute for research in immunology and cancer located in Montreol, Canada, has acheive improved results at treating Cancer patients with Ribavirin – a common anti-viral drug. The new treatment can be useful in 30% of Cancer diseases include the most common ones.

Read the full story (ScienceDaily)

1. Bobby Maness Says:
   December 14th, 2009 at 23:29

   Just keep making good stuff.

2. Luise Finlayson Says:
   March 6th, 2010 at 23:01

   Very good post but difficult to understand cause I’m spanish speaker

You must be logged in to post a comment.